"Avoidable Deaths" - Union for International Cancer Control

"Back to Basics: The Concept of HRQL Under a Magnifying Glass" - EORTC Quality of Life Group

"Bald for a Cause" initiative - UWC Dilijan College

Aakash Desai: Some Key Takeaways ASCO Tips

Applications are open for the Editorial Fellowship at the Journal of Immunotherapy and Precision Oncology

Ursula Sansom-Daly: Families hopes and fears about precision medicine in Childhood Cancer

Phuong Gallagher: I'm delighted that the NCI OCS is highlighting survivor voices for National Cancer Survivors' Month

Navneet Singh: A couple of publications coinciding with end of 2024

Dissecting the Role of FOXR2 in the Oncogenesis of Diffuse Intrinsic Pontine Glioma

drug

Jan 19, 2024

Vivek Subbiah: We need to break free from “me too” compounds

Aug 20, 2023

Vivek Subbiah: Pan-KRAS inhibitors have broad therapeutic implications and merit clinical investigation in patients with KRAS-driven cancers.

Aug 12, 2023

Aaron Goodman: LOTIS-9 Trial in diffuse large B-cell lymphoma Pauses Enrollment Due to Respiratory Toxicities

Jul 24, 2023

Unfortunately another very expensive drug fail in MDS – Aaron Goodman

Jul 16, 2023

We are proud to join with AARP and 35 other orgs to push for competition to lower drug prices – David Mitchell

Jul 11, 2023

First patient dosed in combination trial of OBT076 and CPI Balstilimab – Oxford BioTherapeutics

Jul 9, 2023

Phase 1 data from the auristatin HER2 ADC PF-06804103 highlight the importance of optimizing the toxicity profile of novel ADCs – Paolo Tarantino

Patrick Soon-Shiong: 30 Years and $3B Toward a Universal Cancer Fighter

Dana Dornsife: After 19 Years, Lazarex Cancer Foundation Is Shuttering Because of Lack of Funding

Matt Sherer: ASCO Supports Permanent Medicare Telehealth

New FDA PreCheck Program to Boost U.S. Drug Manufacturing